Close association between polymorphisms of the nitric oxide synthetase 3 gene and neurological disorders other than stroke by Kapoor, Shailendra
© 2012 Kapoor, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of General Medicine 2012:5 431–432
International Journal of General Medicine
Close association between polymorphisms of the 
nitric oxide synthetase 3 gene and neurological 
disorders other than stroke
Shailendra Kapoor
Richmond, VA, USA
Correspondence: Shailendra Kapoor 
2300 E Cary Street, Richmond,  
VA 23223, USA 
Email shailendrakapoor@yahoo.com
To the editor
I read with great interest the article by Du et al in a recent issue of your journal.1 The 
article makes highly interesting reading. Interestingly, the past few years have seen 
the discovery of a number of close associations between polymorphisms of the nitric 
oxide synthetase 3 (NOS3) gene and neurological diseases other than stroke.
For instance, increased expression of NOS3 results in altered mitochondrial function 
in neurons. As a consequence, the intracellular levels of reactive oxygen species are 
accentuated, as are the levels of p53 and Bax, resulting in the dementia and neurodegen-
eration seen in individuals with Alzheimer’s disease.2 The G894T polymorphism acts 
as a risk factor for sporadic frontotemporal lobar degeneration. In fact, in a recent study, 
Venturelli et al have reported an incidence rate of 40% for the G894T polymorphism 
in individuals afflicted with frontotemporal lobar degeneration.3 Similarly, the risk of 
post-stroke dementia is increased in stroke patients with the rs1799983 polymorphism 
of the NOS3 gene. For instance, the hazard ratio is 3.14 in stroke patients with the 
TT genotype in comparison with those having the GG genotype.4
Similarly, individuals with Pick’s disease and Lewy body disease demonstrate 
altered NOS3 expression and accelerated proliferation of NOS3-positive neurons.5 
An increased incidence of Parkinson’s disease is also associated with the rs12829185 
and rs3782218 polymorphisms of the NOS1 gene and the rs944725 polymorphism 
of the NOS2A gene.6 Further, Sohn et al have recently demonstrated increased prolif-
eration of NOS3-expressing glial cells in amyotrophic lateral sclerosis, as well as in 
progressive supranuclear palsy.5
The above examples illustrate a clear association between NOS3 and many neu-
rological diseases, ranging from Alzheimer’s disease to Pick’s disease. Modulation of 
NOS3 function may alter and beneficially attenuate the progression of these diseases. 
Hopefully, the coming years will see the development of these NOS3 modulators.
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